Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples